April 27 (Reuters) – Eli Lilly said on Monday it would buy privately-held blood cancer treatment developer Ajax Therapeutics for up to $2.3 billion in cash.
(Reporting by Christy Santhosh in Bengaluru; Editing by Maju Samuel)
Brought to you by www.srnnews.com